A - Human Necessities – 61 – F
Patent
A - Human Necessities
61
F
A61F 9/00 (2006.01) A61M 11/00 (2006.01)
Patent
CA 2240322
The bioavailability of an ophthalmologically active compound is increased by its provision in a dosage of ophthalmic treatment liquid which takes the form of a jet or stream of droplets. Such a jet or stream can be directed or targeted at a particular site in the eye where the compound can be best absorbed.
On améliore la biodisponibilité d'un composé actif sur le plan ophtalmologique en le produisant dans une dose de liquide de traitement ophtalmique sous la forme d'un jet ou d'un écoulement de gouttelettes. On peut diriger ou pointer ce jet ou cet écoulement vers un emplacement déterminé de l'oeil, ce qui optimise l'absorption du composé.
Embleton Jonathan Kenneth
Malcolmson Richard Joseph
Martini Luigi Gerard
Gierczak Eugene J. A.
Pfizer Health Ab
Pharmacia & Upjohn Ab
LandOfFree
Ophthalmic treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1735143